nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolutegravir—UGT1A1—Mycophenolate mofetil—systemic lupus erythematosus	0.553	1	CbGbCtD
Dolutegravir—UGT1A1—urine—systemic lupus erythematosus	0.0226	0.335	CbGeAlD
Dolutegravir—POU2F2—BCR signaling pathway—FCGR2B—systemic lupus erythematosus	0.0195	0.146	CbGpPWpGaD
Dolutegravir—POU2F2—lymphoid tissue—systemic lupus erythematosus	0.0152	0.225	CbGeAlD
Dolutegravir—POU2F2—lung—systemic lupus erythematosus	0.0126	0.186	CbGeAlD
Dolutegravir—POU2F2—BCR signaling pathway—CSK—systemic lupus erythematosus	0.0123	0.0916	CbGpPWpGaD
Dolutegravir—UGT1A1—blood plasma—systemic lupus erythematosus	0.0118	0.175	CbGeAlD
Dolutegravir—POU2F2—BCR signaling pathway—LYN—systemic lupus erythematosus	0.0111	0.0833	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—ETS1—systemic lupus erythematosus	0.0109	0.0817	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—PTPRC—systemic lupus erythematosus	0.00954	0.0713	CbGpPWpGaD
Dolutegravir—POU2F2—Validated transcriptional targets of deltaNp63 isoforms—VDR—systemic lupus erythematosus	0.00928	0.0693	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—C4A—systemic lupus erythematosus	0.00924	0.069	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—C4B—systemic lupus erythematosus	0.00924	0.069	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—CD79A—systemic lupus erythematosus	0.00834	0.0623	CbGpPWpGaD
Dolutegravir—UGT1A1—kidney—systemic lupus erythematosus	0.00536	0.0792	CbGeAlD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	0.00483	0.0361	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	0.00346	0.0258	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	0.0032	0.0239	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—CCL2—systemic lupus erythematosus	0.00264	0.0197	CbGpPWpGaD
Dolutegravir—UGT1A1—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.00201	0.015	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	0.00182	0.0136	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	0.00172	0.0128	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	0.00162	0.0121	CbGpPWpGaD
Dolutegravir—UGT1A1—Phase II conjugation—NAT2—systemic lupus erythematosus	0.0016	0.0119	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	0.00154	0.0115	CbGpPWpGaD
Dolutegravir—Blood creatinine increased—Mycophenolate mofetil—systemic lupus erythematosus	0.0014	0.00571	CcSEcCtD
Dolutegravir—Abdominal pain upper—Cyclosporine—systemic lupus erythematosus	0.0014	0.00571	CcSEcCtD
Dolutegravir—Hepatitis—Leflunomide—systemic lupus erythematosus	0.00137	0.0056	CcSEcCtD
Dolutegravir—Urinary tract disorder—Leflunomide—systemic lupus erythematosus	0.00136	0.00554	CcSEcCtD
Dolutegravir—Urethral disorder—Leflunomide—systemic lupus erythematosus	0.00135	0.00549	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Mycophenolate mofetil—systemic lupus erythematosus	0.00132	0.00538	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	0.00132	0.00983	CbGpPWpGaD
Dolutegravir—Immune system disorder—Azathioprine—systemic lupus erythematosus	0.00131	0.00536	CcSEcCtD
Dolutegravir—Abdominal discomfort—Cyclosporine—systemic lupus erythematosus	0.00127	0.00518	CcSEcCtD
Dolutegravir—Abdominal pain upper—Hydrocortisone—systemic lupus erythematosus	0.00124	0.00508	CcSEcCtD
Dolutegravir—Immune system disorder—Leflunomide—systemic lupus erythematosus	0.00124	0.00506	CcSEcCtD
Dolutegravir—Neutropenia—Mycophenolate mofetil—systemic lupus erythematosus	0.00121	0.00493	CcSEcCtD
Dolutegravir—Mental disorder—Leflunomide—systemic lupus erythematosus	0.0012	0.00491	CcSEcCtD
Dolutegravir—Inflammation—Methotrexate—systemic lupus erythematosus	0.0012	0.00491	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Hydrocortisone—systemic lupus erythematosus	0.0012	0.0049	CcSEcCtD
Dolutegravir—Hyperglycaemia—Cyclosporine—systemic lupus erythematosus	0.0012	0.00487	CcSEcCtD
Dolutegravir—Flatulence—Leflunomide—systemic lupus erythematosus	0.00118	0.00481	CcSEcCtD
Dolutegravir—Hyperglycaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.00117	0.00476	CcSEcCtD
Dolutegravir—Vomiting—Dapsone—systemic lupus erythematosus	0.00116	0.00474	CcSEcCtD
Dolutegravir—Renal failure—Cyclosporine—systemic lupus erythematosus	0.00116	0.00474	CcSEcCtD
Dolutegravir—Headache—Dapsone—systemic lupus erythematosus	0.00115	0.00467	CcSEcCtD
Dolutegravir—Renal failure—Mycophenolate mofetil—systemic lupus erythematosus	0.00113	0.00462	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Methylprednisolone—systemic lupus erythematosus	0.00113	0.0046	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Cyclosporine—systemic lupus erythematosus	0.00112	0.00456	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Mycophenolate mofetil—systemic lupus erythematosus	0.00109	0.00445	CcSEcCtD
Dolutegravir—Nausea—Dapsone—systemic lupus erythematosus	0.00109	0.00443	CcSEcCtD
Dolutegravir—Vertigo—Leflunomide—systemic lupus erythematosus	0.00108	0.00438	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic lupus erythematosus	0.00107	0.00437	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	0.00106	0.00793	CbGpPWpGaD
Dolutegravir—Hepatitis—Cyclosporine—systemic lupus erythematosus	0.00106	0.00433	CcSEcCtD
Dolutegravir—Urinary tract disorder—Cyclosporine—systemic lupus erythematosus	0.00105	0.00427	CcSEcCtD
Dolutegravir—Urethral disorder—Cyclosporine—systemic lupus erythematosus	0.00104	0.00424	CcSEcCtD
Dolutegravir—Hepatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.00103	0.00422	CcSEcCtD
Dolutegravir—Urinary tract disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00102	0.00417	CcSEcCtD
Dolutegravir—Urethral disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00101	0.00414	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic lupus erythematosus	0.00101	0.00413	CcSEcCtD
Dolutegravir—Skin disorder—Azathioprine—systemic lupus erythematosus	0.001	0.0041	CcSEcCtD
Dolutegravir—Nervous system disorder—Leflunomide—systemic lupus erythematosus	0.000958	0.00391	CcSEcCtD
Dolutegravir—Skin disorder—Leflunomide—systemic lupus erythematosus	0.000949	0.00387	CcSEcCtD
Dolutegravir—UGT1A1—Biological oxidations—NAT2—systemic lupus erythematosus	0.000936	0.00699	CbGpPWpGaD
Dolutegravir—Mental disorder—Cyclosporine—systemic lupus erythematosus	0.00093	0.00379	CcSEcCtD
Dolutegravir—UGT1A1—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000923	0.00689	CbGpPWpGaD
Dolutegravir—Flatulence—Cyclosporine—systemic lupus erythematosus	0.00091	0.00371	CcSEcCtD
Dolutegravir—Hyperglycaemia—Dexamethasone—systemic lupus erythematosus	0.000908	0.0037	CcSEcCtD
Dolutegravir—Hyperglycaemia—Betamethasone—systemic lupus erythematosus	0.000908	0.0037	CcSEcCtD
Dolutegravir—Mental disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000907	0.0037	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Prednisone—systemic lupus erythematosus	0.000894	0.00365	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000893	0.00364	CcSEcCtD
Dolutegravir—Flatulence—Mycophenolate mofetil—systemic lupus erythematosus	0.000888	0.00362	CcSEcCtD
Dolutegravir—Insomnia—Leflunomide—systemic lupus erythematosus	0.000883	0.0036	CcSEcCtD
Dolutegravir—Immune system disorder—Hydrocortisone—systemic lupus erythematosus	0.000852	0.00347	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Azathioprine—systemic lupus erythematosus	0.000846	0.00345	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.000843	0.00344	CcSEcCtD
Dolutegravir—Fatigue—Leflunomide—systemic lupus erythematosus	0.000842	0.00343	CcSEcCtD
Dolutegravir—Vertigo—Cyclosporine—systemic lupus erythematosus	0.00083	0.00338	CcSEcCtD
Dolutegravir—Mental disorder—Hydrocortisone—systemic lupus erythematosus	0.000826	0.00337	CcSEcCtD
Dolutegravir—Neutropenia—Prednisone—systemic lupus erythematosus	0.00082	0.00334	CcSEcCtD
Dolutegravir—Abdominal pain—Azathioprine—systemic lupus erythematosus	0.000818	0.00333	CcSEcCtD
Dolutegravir—Vertigo—Mycophenolate mofetil—systemic lupus erythematosus	0.000809	0.0033	CcSEcCtD
Dolutegravir—Immune system disorder—Methylprednisolone—systemic lupus erythematosus	0.0008	0.00326	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Leflunomide—systemic lupus erythematosus	0.000799	0.00326	CcSEcCtD
Dolutegravir—Hyperglycaemia—Prednisone—systemic lupus erythematosus	0.000791	0.00322	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.000781	0.00318	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	0.00078	0.00583	CbGpPWpGaD
Dolutegravir—Mental disorder—Methylprednisolone—systemic lupus erythematosus	0.000776	0.00316	CcSEcCtD
Dolutegravir—Abdominal pain—Leflunomide—systemic lupus erythematosus	0.000772	0.00315	CcSEcCtD
Dolutegravir—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.000762	0.00311	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000762	0.00311	CcSEcCtD
Dolutegravir—Vertigo—Prednisolone—systemic lupus erythematosus	0.000755	0.00308	CcSEcCtD
Dolutegravir—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000739	0.00301	CcSEcCtD
Dolutegravir—Vertigo—Hydrocortisone—systemic lupus erythematosus	0.000737	0.00301	CcSEcCtD
Dolutegravir—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000732	0.00299	CcSEcCtD
Dolutegravir—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000721	0.00294	CcSEcCtD
Dolutegravir—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.00072	0.00293	CcSEcCtD
Dolutegravir—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000714	0.00291	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	0.000709	0.00529	CbGpPWpGaD
Dolutegravir—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000708	0.00289	CcSEcCtD
Dolutegravir—Abdominal discomfort—Methotrexate—systemic lupus erythematosus	0.000702	0.00286	CcSEcCtD
Dolutegravir—Asthenia—Leflunomide—systemic lupus erythematosus	0.000701	0.00286	CcSEcCtD
Dolutegravir—Vertigo—Triamcinolone—systemic lupus erythematosus	0.000694	0.00283	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000694	0.00283	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	0.000693	0.00518	CbGpPWpGaD
Dolutegravir—Vertigo—Methylprednisolone—systemic lupus erythematosus	0.000693	0.00282	CcSEcCtD
Dolutegravir—Pruritus—Leflunomide—systemic lupus erythematosus	0.000691	0.00282	CcSEcCtD
Dolutegravir—Neutropenia—Methotrexate—systemic lupus erythematosus	0.000685	0.00279	CcSEcCtD
Dolutegravir—Dizziness—Azathioprine—systemic lupus erythematosus	0.000684	0.00279	CcSEcCtD
Dolutegravir—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000682	0.00278	CcSEcCtD
Dolutegravir—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000668	0.00272	CcSEcCtD
Dolutegravir—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.000665	0.00271	CcSEcCtD
Dolutegravir—Vomiting—Azathioprine—systemic lupus erythematosus	0.000658	0.00268	CcSEcCtD
Dolutegravir—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000657	0.00268	CcSEcCtD
Dolutegravir—Rash—Azathioprine—systemic lupus erythematosus	0.000652	0.00266	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000652	0.00266	CcSEcCtD
Dolutegravir—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000652	0.00266	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000651	0.00265	CcSEcCtD
Dolutegravir—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000651	0.00265	CcSEcCtD
Dolutegravir—Fatigue—Cyclosporine—systemic lupus erythematosus	0.00065	0.00265	CcSEcCtD
Dolutegravir—Headache—Azathioprine—systemic lupus erythematosus	0.000648	0.00264	CcSEcCtD
Dolutegravir—Dizziness—Leflunomide—systemic lupus erythematosus	0.000646	0.00263	CcSEcCtD
Dolutegravir—Renal failure—Methotrexate—systemic lupus erythematosus	0.000642	0.00262	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000635	0.00259	CcSEcCtD
Dolutegravir—Immune system disorder—Prednisone—systemic lupus erythematosus	0.000634	0.00258	CcSEcCtD
Dolutegravir—Vertigo—Dexamethasone—systemic lupus erythematosus	0.00063	0.00257	CcSEcCtD
Dolutegravir—Vertigo—Betamethasone—systemic lupus erythematosus	0.00063	0.00257	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	0.000622	0.00465	CbGpPWpGaD
Dolutegravir—Vomiting—Leflunomide—systemic lupus erythematosus	0.000621	0.00253	CcSEcCtD
Dolutegravir—Insomnia—Prednisolone—systemic lupus erythematosus	0.00062	0.00253	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.000618	0.00252	CcSEcCtD
Dolutegravir—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000617	0.00252	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000616	0.00251	CcSEcCtD
Dolutegravir—Rash—Leflunomide—systemic lupus erythematosus	0.000616	0.00251	CcSEcCtD
Dolutegravir—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000615	0.00251	CcSEcCtD
Dolutegravir—Mental disorder—Prednisone—systemic lupus erythematosus	0.000615	0.00251	CcSEcCtD
Dolutegravir—Nausea—Azathioprine—systemic lupus erythematosus	0.000614	0.0025	CcSEcCtD
Dolutegravir—Headache—Leflunomide—systemic lupus erythematosus	0.000612	0.00249	CcSEcCtD
Dolutegravir—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000611	0.00249	CcSEcCtD
Dolutegravir—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000606	0.00247	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000601	0.00245	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—RXRA—systemic lupus erythematosus	0.000598	0.00447	CbGpPWpGaD
Dolutegravir—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000596	0.00243	CcSEcCtD
Dolutegravir—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000586	0.00239	CcSEcCtD
Dolutegravir—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000581	0.00237	CcSEcCtD
Dolutegravir—Nausea—Leflunomide—systemic lupus erythematosus	0.00058	0.00237	CcSEcCtD
Dolutegravir—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000579	0.00236	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000578	0.00236	CcSEcCtD
Dolutegravir—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000578	0.00235	CcSEcCtD
Dolutegravir—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000575	0.00234	CcSEcCtD
Dolutegravir—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000571	0.00233	CcSEcCtD
Dolutegravir—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000569	0.00232	CcSEcCtD
Dolutegravir—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000561	0.00229	CcSEcCtD
Dolutegravir—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000561	0.00229	CcSEcCtD
Dolutegravir—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000555	0.00226	CcSEcCtD
Dolutegravir—Vertigo—Prednisone—systemic lupus erythematosus	0.000549	0.00224	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000548	0.00223	CcSEcCtD
Dolutegravir—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000544	0.00222	CcSEcCtD
Dolutegravir—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000543	0.00221	CcSEcCtD
Dolutegravir—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000542	0.00221	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	0.000541	0.00404	CbGpPWpGaD
Dolutegravir—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000541	0.0022	CcSEcCtD
Dolutegravir—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000533	0.00217	CcSEcCtD
Dolutegravir—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.00053	0.00216	CcSEcCtD
Dolutegravir—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.00053	0.00216	CcSEcCtD
Dolutegravir—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000528	0.00215	CcSEcCtD
Dolutegravir—UGT1A1—Biological oxidations—RXRA—systemic lupus erythematosus	0.000524	0.00392	CbGpPWpGaD
Dolutegravir—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.00052	0.00212	CcSEcCtD
Dolutegravir—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000518	0.00211	CcSEcCtD
Dolutegravir—Insomnia—Betamethasone—systemic lupus erythematosus	0.000518	0.00211	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000516	0.00211	CcSEcCtD
Dolutegravir—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000516	0.0021	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000515	0.0021	CcSEcCtD
Dolutegravir—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000514	0.00209	CcSEcCtD
Dolutegravir—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000505	0.00206	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	0.000505	0.00377	CbGpPWpGaD
Dolutegravir—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000503	0.00205	CcSEcCtD
Dolutegravir—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000498	0.00203	CcSEcCtD
Dolutegravir—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000498	0.00203	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000494	0.00201	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000494	0.00201	CcSEcCtD
Dolutegravir—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000494	0.00201	CcSEcCtD
Dolutegravir—Fatigue—Betamethasone—systemic lupus erythematosus	0.000493	0.00201	CcSEcCtD
Dolutegravir—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000493	0.00201	CcSEcCtD
Dolutegravir—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000489	0.00199	CcSEcCtD
Dolutegravir—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000486	0.00198	CcSEcCtD
Dolutegravir—Skin disorder—Prednisone—systemic lupus erythematosus	0.000484	0.00197	CcSEcCtD
Dolutegravir—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000481	0.00196	CcSEcCtD
Dolutegravir—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000479	0.00195	CcSEcCtD
Dolutegravir—Rash—Cyclosporine—systemic lupus erythematosus	0.000475	0.00194	CcSEcCtD
Dolutegravir—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000475	0.00194	CcSEcCtD
Dolutegravir—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000474	0.00193	CcSEcCtD
Dolutegravir—Headache—Cyclosporine—systemic lupus erythematosus	0.000472	0.00193	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000468	0.00191	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000468	0.00191	CcSEcCtD
Dolutegravir—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000468	0.00191	CcSEcCtD
Dolutegravir—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000465	0.00189	CcSEcCtD
Dolutegravir—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000464	0.00189	CcSEcCtD
Dolutegravir—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000464	0.00189	CcSEcCtD
Dolutegravir—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000463	0.00189	CcSEcCtD
Dolutegravir—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000461	0.00188	CcSEcCtD
Dolutegravir—Vertigo—Methotrexate—systemic lupus erythematosus	0.000459	0.00187	CcSEcCtD
Dolutegravir—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000458	0.00187	CcSEcCtD
Dolutegravir—Dizziness—Prednisolone—systemic lupus erythematosus	0.000454	0.00185	CcSEcCtD
Dolutegravir—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000453	0.00185	CcSEcCtD
Dolutegravir—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000452	0.00184	CcSEcCtD
Dolutegravir—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000452	0.00184	CcSEcCtD
Dolutegravir—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000452	0.00184	CcSEcCtD
Dolutegravir—Insomnia—Prednisone—systemic lupus erythematosus	0.000451	0.00184	CcSEcCtD
Dolutegravir—Nausea—Cyclosporine—systemic lupus erythematosus	0.000448	0.00183	CcSEcCtD
Dolutegravir—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000446	0.00182	CcSEcCtD
Dolutegravir—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000445	0.00182	CcSEcCtD
Dolutegravir—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000443	0.00181	CcSEcCtD
Dolutegravir—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000437	0.00178	CcSEcCtD
Dolutegravir—Rash—Prednisolone—systemic lupus erythematosus	0.000432	0.00176	CcSEcCtD
Dolutegravir—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000432	0.00176	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000432	0.00176	CcSEcCtD
Dolutegravir—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000431	0.00176	CcSEcCtD
Dolutegravir—Fatigue—Prednisone—systemic lupus erythematosus	0.00043	0.00175	CcSEcCtD
Dolutegravir—Headache—Prednisolone—systemic lupus erythematosus	0.00043	0.00175	CcSEcCtD
Dolutegravir—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000426	0.00174	CcSEcCtD
Dolutegravir—Rash—Hydrocortisone—systemic lupus erythematosus	0.000422	0.00172	CcSEcCtD
Dolutegravir—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000422	0.00172	CcSEcCtD
Dolutegravir—Headache—Hydrocortisone—systemic lupus erythematosus	0.00042	0.00171	CcSEcCtD
Dolutegravir—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000417	0.0017	CcSEcCtD
Dolutegravir—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000416	0.0017	CcSEcCtD
Dolutegravir—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000411	0.00167	CcSEcCtD
Dolutegravir—Asthenia—Betamethasone—systemic lupus erythematosus	0.000411	0.00167	CcSEcCtD
Dolutegravir—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000409	0.00167	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000408	0.00166	CcSEcCtD
Dolutegravir—Nausea—Prednisolone—systemic lupus erythematosus	0.000407	0.00166	CcSEcCtD
Dolutegravir—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000405	0.00165	CcSEcCtD
Dolutegravir—Pruritus—Betamethasone—systemic lupus erythematosus	0.000405	0.00165	CcSEcCtD
Dolutegravir—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000405	0.00165	CcSEcCtD
Dolutegravir—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000401	0.00164	CcSEcCtD
Dolutegravir—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.0004	0.00163	CcSEcCtD
Dolutegravir—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000398	0.00162	CcSEcCtD
Dolutegravir—Rash—Triamcinolone—systemic lupus erythematosus	0.000398	0.00162	CcSEcCtD
Dolutegravir—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000397	0.00162	CcSEcCtD
Dolutegravir—Rash—Methylprednisolone—systemic lupus erythematosus	0.000397	0.00162	CcSEcCtD
Dolutegravir—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000396	0.00162	CcSEcCtD
Dolutegravir—Headache—Triamcinolone—systemic lupus erythematosus	0.000395	0.00161	CcSEcCtD
Dolutegravir—Headache—Methylprednisolone—systemic lupus erythematosus	0.000394	0.00161	CcSEcCtD
Dolutegravir—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000394	0.00161	CcSEcCtD
Dolutegravir—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000392	0.0016	CcSEcCtD
Dolutegravir—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000392	0.0016	CcSEcCtD
Dolutegravir—Dizziness—Betamethasone—systemic lupus erythematosus	0.000378	0.00154	CcSEcCtD
Dolutegravir—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000378	0.00154	CcSEcCtD
Dolutegravir—Insomnia—Methotrexate—systemic lupus erythematosus	0.000377	0.00154	CcSEcCtD
Dolutegravir—Nausea—Triamcinolone—systemic lupus erythematosus	0.000375	0.00153	CcSEcCtD
Dolutegravir—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000374	0.00152	CcSEcCtD
Dolutegravir—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000367	0.0015	CcSEcCtD
Dolutegravir—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000364	0.00148	CcSEcCtD
Dolutegravir—Vomiting—Betamethasone—systemic lupus erythematosus	0.000364	0.00148	CcSEcCtD
Dolutegravir—Rash—Betamethasone—systemic lupus erythematosus	0.000361	0.00147	CcSEcCtD
Dolutegravir—Rash—Dexamethasone—systemic lupus erythematosus	0.000361	0.00147	CcSEcCtD
Dolutegravir—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000361	0.00147	CcSEcCtD
Dolutegravir—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000361	0.00147	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.00036	0.00147	CcSEcCtD
Dolutegravir—Fatigue—Methotrexate—systemic lupus erythematosus	0.000359	0.00146	CcSEcCtD
Dolutegravir—Headache—Dexamethasone—systemic lupus erythematosus	0.000359	0.00146	CcSEcCtD
Dolutegravir—Headache—Betamethasone—systemic lupus erythematosus	0.000359	0.00146	CcSEcCtD
Dolutegravir—Asthenia—Prednisone—systemic lupus erythematosus	0.000358	0.00146	CcSEcCtD
Dolutegravir—Pruritus—Prednisone—systemic lupus erythematosus	0.000353	0.00144	CcSEcCtD
Dolutegravir—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000341	0.00139	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000341	0.00139	CcSEcCtD
Dolutegravir—Nausea—Dexamethasone—systemic lupus erythematosus	0.00034	0.00139	CcSEcCtD
Dolutegravir—Nausea—Betamethasone—systemic lupus erythematosus	0.00034	0.00139	CcSEcCtD
Dolutegravir—Dizziness—Prednisone—systemic lupus erythematosus	0.00033	0.00134	CcSEcCtD
Dolutegravir—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000329	0.00134	CcSEcCtD
Dolutegravir—Vomiting—Prednisone—systemic lupus erythematosus	0.000317	0.00129	CcSEcCtD
Dolutegravir—Rash—Prednisone—systemic lupus erythematosus	0.000314	0.00128	CcSEcCtD
Dolutegravir—Dermatitis—Prednisone—systemic lupus erythematosus	0.000314	0.00128	CcSEcCtD
Dolutegravir—Headache—Prednisone—systemic lupus erythematosus	0.000312	0.00127	CcSEcCtD
Dolutegravir—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000307	0.00125	CcSEcCtD
Dolutegravir—Asthenia—Methotrexate—systemic lupus erythematosus	0.000299	0.00122	CcSEcCtD
Dolutegravir—Nausea—Prednisone—systemic lupus erythematosus	0.000296	0.00121	CcSEcCtD
Dolutegravir—Pruritus—Methotrexate—systemic lupus erythematosus	0.000295	0.0012	CcSEcCtD
Dolutegravir—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000285	0.00116	CcSEcCtD
Dolutegravir—Dizziness—Methotrexate—systemic lupus erythematosus	0.000275	0.00112	CcSEcCtD
Dolutegravir—Vomiting—Methotrexate—systemic lupus erythematosus	0.000265	0.00108	CcSEcCtD
Dolutegravir—Rash—Methotrexate—systemic lupus erythematosus	0.000263	0.00107	CcSEcCtD
Dolutegravir—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000262	0.00107	CcSEcCtD
Dolutegravir—Headache—Methotrexate—systemic lupus erythematosus	0.000261	0.00106	CcSEcCtD
Dolutegravir—Nausea—Methotrexate—systemic lupus erythematosus	0.000247	0.00101	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—TGFB1—systemic lupus erythematosus	0.000215	0.0016	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NAT2—systemic lupus erythematosus	0.00016	0.0012	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—RXRA—systemic lupus erythematosus	8.97e-05	0.00067	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPARG—systemic lupus erythematosus	5.66e-05	0.000423	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ALB—systemic lupus erythematosus	5.09e-05	0.00038	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NOS3—systemic lupus erythematosus	4.87e-05	0.000364	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PTGS2—systemic lupus erythematosus	4.45e-05	0.000333	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—EP300—systemic lupus erythematosus	3.7e-05	0.000277	CbGpPWpGaD
